Name: UMIN ID:
| Unique ID issued by UMIN | UMIN000047758 |
|---|---|
| Receipt number | R000054447 |
| Scientific Title | Multicenter study for biomarker on therapeutic effect and safety of Atezolizumab + Bevacizumab in patients with unresectable hepatocellular carcinoma |
| Date of disclosure of the study information | 2022/05/16 |
| Last modified on | 2025/05/16 15:44:42 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2022/05/14 23:58:22 | ||
| 2 | Update | 2022/05/16 19:05:03 | Name of primary person or sponsor |
|
| 3 | Update | 2023/05/15 09:10:55 | Recruitment status |
|
| 4 | Update | 2023/11/15 19:16:47 | Number of participants that the trial has enrolled |
|
| 5 | Update | 2025/05/16 15:43:25 | Publication of results |
|
| 6 | Update | 2025/05/16 15:44:42 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization |